Osman Kibar

Osman Kibar is a Turkish-American entrepreneur and scientist, best known as the founder and CEO of Samumed, a biopharmaceutical company focused on tissue regeneration.

Early Life and Education

Osman Kibar was born in Izmir, Turkey. He moved to the United States for his higher education, earning a Bachelor of Science degree in Electrical Engineering from California Institute of Technology (Caltech) and a Ph.D. in Optics from the University of California, San Diego (UCSD).

Career

After completing his Ph.D., Kibar co-founded Genoptix, a specialized laboratory service provider, which was later sold to Novartis for $470 million in 2011. He then founded Samumed, a company that aims to harness the regenerative power of the Wnt signaling pathway to reverse age-related degeneration and treat diseases such as osteoarthritis, baldness, and cancer.

Recognition

Kibar has been recognized for his contributions to the field of biotechnology. In 2016, he was named in the Forbes list of global billionaires, with an estimated net worth of $4 billion. He was also listed in the PharmaVOICE 100, a list of the most inspiring people in the life sciences industry.

See Also

• Biotechnology
• Pharmaceutical industry
• Regenerative medicine

References

<references />

External Links

• Samumed Official Website

This article is a stub related to pharmacology. You can help WikiMD by expanding it!